Lingotto
7 Seymour Street, London, W1H 7JW, United Kingdom
Overview
Lingotto is an investment management company owned by Exor N.V. and launched by the Italian dynasty the Agnelli family. The company possesses a set of distinctive competitive edges that distinguish it in the market. One key strength lies in its unique investment strategies, which are complementary, differentiated, and unparalleled, providing a competitive advantage over its peers. Moreover, the company has fostered a culture of partnership, promoting autonomy and cooperation among its stakeholders. This collaborative approach not only enhances teamwork but also strengthens relationships within the organization. Another significant aspect of the company's operations is its unwavering commitment to accountability, integrity, and transparency, ensuring a high level of trust and reliability for its clients and partners.
- Total investments
- 27
- Lead investments
- 6
- Investments · 12mo
- 13
- Active investors
- 5
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Lumilens
Participated · Series C · Aug 2026
Lumilens develops photonic connectivity solutions intended to connect thousands or hundreds of thousands of GPUs so they can operate as a single system, addressing the limits of copper-based scale-out networks. The team moved from founding to defining, qualifying and shipping its first product within about two years, and that product is deployed in a hyperscaler’s production AI data centers under a multi-billion-dollar agreement. Lumilens emerged from stealth concurrent with its announced raise of more than $900 million from a syndicate of venture and institutional investors. Management says the funding will support building out infrastructure and developing additional products on its roadmap. The company positions itself at the intersection of optics and AI infrastructure to overcome physical constraints on GPU-scale networking.
- Andromeda Surgical
Participated · Series A · Aug 2026
Andromeda Surgical is developing an autonomous surgery platform and is beginning clinical and commercial activity in endourology. The company is initially focusing on procedures that treat BPH, prostate cancer, bladder cancer, and kidney stones, and reports that urologists in three countries have used its platform to perform holmium laser enucleation of the prostate (HoLEP) in more than 40 patients. It has observed enucleation times as fast as 30 minutes versus a published average of about 90 minutes. The team combines surgical deeptech and healthcare expertise from organizations including Neuralink, Science Corp, Avail, and the group that launched the first autonomous truck at Starsky Robotics. Andromeda has raised $30 million to date, including a $15 million Series A, and has been cleared to launch commercially in Canada and New Zealand. The company plans to deploy its first commercial systems into hospitals in the coming months and to scale utilization while expanding into additional procedures and autonomous capabilities.
- Minerva
Participated · Series A · Jun 2026
Led by Jackson Engles, Daniel Saedi and Matthew Joseph, Minerva provides an AI-driven platform that helps brands unify and standardize first-party customer data, enrich it with a proprietary identity graph and more than 1,000 attributes, and create, analyze and optimize marketing campaigns at scale. The platform includes an Agentic Data Engineer to unlock customer data, tools for campaign creation and optimization, and measurement and reporting capabilities. Minerva works with consumer brands across sports, hospitality, financial services, real estate and travel, and its customers include the NBA, Juicebox, Luxury Presence, Trust & Will and Wander. The company plans to use the newly raised $20M to expand engineering, research and go-to-market teams and to build a self-serve product. The announcement also referenced a collaboration with OpenAI. No revenue, valuation or previous funding details were disclosed in the articles.
- NEURA Robotics
Participated · Series C · Jun 2026
Founded in 2019 by David Reger in Metzingen, Germany, NEURA Robotics builds ‘cognitive’ robots that can see, hear, sense their surroundings and learn from experience. The company integrates sensors, AI software and robotic hardware into single devices, likening its machines to a “smartphone with arms and legs.” In addition to hardware, it offers the Neuraverse software platform, which enables the safe deployment and interaction of intelligent robots with humans. NEURA serves both industrial and consumer markets and has disclosed nearly $1 billion worth of purchase orders from customers such as Kawasaki Heavy Industries and Omron. Management is focused on accelerating humanoid robot development and scaling production capacity. Financially, the firm previously secured €120 million in January 2025 and is now pursuing a much larger raise to fund expansion. If successful, the new round could push the company’s valuation to approximately €4 billion.
- Antes
Led · Seed · Apr 2026
Antes develops AI-driven compliance software aimed at helping engineers and legal teams manage complex regulatory and homologation workflows. Its product roadmap includes a standalone interface that notifies engineers of new regulations and a tool to verify that new part designs conform to relevant standards. The company aggregates and verifies both publicly available and proprietary regulatory data and intends to incorporate aggregated customer usage data into its products. Antes is targeting complex manufacturing sectors such as aerospace, automotive and defense. The company was founded in 2024 by Rongfei Lu and Nick Goodson and is based in San Francisco. As of the seed round, Antes has seven employees and plans to hire additional specialized engineering and domain experts to build its platform.